Book contents
- Observation Medicine
- Observation Medicine
- Copyright page
- Contents
- Advance Praise
- About the Editors
- Contributors
- Foreword: Onward and Upward
- Preface
- Part I Administration: Key Concepts of Observation Medicine, and Developing and Maintaining an Observation Unit
- Part II Observation Medicine: Clinical Setting and Education
- Part III New Developments in Observation Medicine
- Part IV Clinical
- Subpart IVA Clinical – Cardiac
- Subpart IVB Clinical – Respiratory
- Subpart IVC Clinical – Vascular
- Chapter 31 Deep Vein Thrombosis (DVT)
- Chapter 32 Acute Pulmonary Embolism (PE)
- Chapter 33 Anticoagulants
- Subpart IVD Clinical – Neurologic
- Subpart IVE Clinical – Metabolic, Endocrine
- Subpart IVF Clinical – Hematologic
- Subpart IVG Clinical – Infections
- Subpart IVH Clinical – Gastrointestinal
- Subpart IVI Clinical – Genitourinary
- Subpart IVJ Clinical – Obstetrics and Gynecology
- Subpart IVK Clinical – Pediatrics and Geriatrics
- Subpart IVL Clinical – Surgical Evaluation
- Subpart IVM Clinical – Pain Management and Musculoskeletal
- Subpart IVN Clinical – Trauma
- Subpart IVO Clinical – Toxicology
- Subpart IVP Clinical – Psychosocial
- Subpart IVQ Clinical – Disasters
- Part V Financial
- Part VI International
- Part VII Evidence Basis for Observation Medicine
- Part VIII Clinical Protocols
- Part IX Administrative Policies
- Part X Order Sets
- Prologue
- Index
- References
Chapter 32 - Acute Pulmonary Embolism (PE)
from Subpart IVC - Clinical – Vascular
Published online by Cambridge University Press: 31 March 2017
Edited by
Book contents
- Observation Medicine
- Observation Medicine
- Copyright page
- Contents
- Advance Praise
- About the Editors
- Contributors
- Foreword: Onward and Upward
- Preface
- Part I Administration: Key Concepts of Observation Medicine, and Developing and Maintaining an Observation Unit
- Part II Observation Medicine: Clinical Setting and Education
- Part III New Developments in Observation Medicine
- Part IV Clinical
- Subpart IVA Clinical – Cardiac
- Subpart IVB Clinical – Respiratory
- Subpart IVC Clinical – Vascular
- Chapter 31 Deep Vein Thrombosis (DVT)
- Chapter 32 Acute Pulmonary Embolism (PE)
- Chapter 33 Anticoagulants
- Subpart IVD Clinical – Neurologic
- Subpart IVE Clinical – Metabolic, Endocrine
- Subpart IVF Clinical – Hematologic
- Subpart IVG Clinical – Infections
- Subpart IVH Clinical – Gastrointestinal
- Subpart IVI Clinical – Genitourinary
- Subpart IVJ Clinical – Obstetrics and Gynecology
- Subpart IVK Clinical – Pediatrics and Geriatrics
- Subpart IVL Clinical – Surgical Evaluation
- Subpart IVM Clinical – Pain Management and Musculoskeletal
- Subpart IVN Clinical – Trauma
- Subpart IVO Clinical – Toxicology
- Subpart IVP Clinical – Psychosocial
- Subpart IVQ Clinical – Disasters
- Part V Financial
- Part VI International
- Part VII Evidence Basis for Observation Medicine
- Part VIII Clinical Protocols
- Part IX Administrative Policies
- Part X Order Sets
- Prologue
- Index
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Observation MedicinePrinciples and Protocols, pp. 165 - 172Publisher: Cambridge University PressPrint publication year: 2017
References
Silverstein, MD, Heit, JA, Mohr, DN, et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998; 158(6): 585–593.CrossRefGoogle ScholarPubMed
White, RH. The epidemiology of venous thromboembolism. Circulation 2003; 107(23 Suppl 1): I4–8.CrossRefGoogle ScholarPubMed
Kearon, C. Natural history of venous thromboembolism. Circulation 2003; 107(23 Suppl 1): I22–30.CrossRefGoogle ScholarPubMed
Dalen, JE, Pulmonary embolism: what have we learned since Virchow? Natural history, pathophysiology, and diagnosis. Chest 2002; 122(4): 1440–1456.CrossRefGoogle ScholarPubMed
Jakobsson, C, Jimenez, D, Gomez, V, et al. Validation of a clinical algorithm to identify low-risk patients with pulmonary embolism. J Thromb Haemost 2010; 8(6): 1242–1247.CrossRefGoogle ScholarPubMed
Jimenez, D, Yusen, RD, Otero, R, et al. Prognostic models for selecting patients with acute pulmonary embolism for initial outpatient therapy. Chest 2007; 132(1): 24–30.CrossRefGoogle ScholarPubMed
Aujesky, D, Perrier, A, Roy, PM, et al. Validation of a clinical prognostic model to identify low-risk patients with pulmonary embolism. J Intern Med 2007; 261(6): 597–604.CrossRefGoogle ScholarPubMed
Janjua, M, Badshah, A, Matta, F, et al. Treatment of acute pulmonary embolism as outpatients or following early discharge. A systematic review. Thromb Haemost 2008; 100(5): 756–761.CrossRefGoogle ScholarPubMed
Agterof, MJ, Schutgens, RE, Snijder, RJ, et al. Out of hospital treatment of acute pulmonary embolism in patients with a low NT-proBNP level. J Thromb Haemost 2010; 8(6): 1235–1241.CrossRefGoogle ScholarPubMed
Zondag, W, Mos, IC, Creemers-Schild, D, et al. Outpatient treatment in patients with acute pulmonary embolism: the Hestia Study. J Thromb Haemost 2011; 9(8): 1500–1507.CrossRefGoogle ScholarPubMed
Agterof, MJ, Schutgens, RE, Moumli, N, et al. A prognostic model for short term adverse events in normotensive patients with pulmonary embolism. Am J Hematol 2011; 86(8): 646–649.CrossRefGoogle ScholarPubMed
Snow, V, Quseem, A, Barry, P, et al. Management of venous thromboembolism: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med 2007; 146(3): 204–210.CrossRefGoogle ScholarPubMed
Torbicki, A, Perrier, A, Konstantinides, S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 2008; 29(18): 2276–2315.Google ScholarPubMed
Aujesky, D, Stone, RA, Kim, S, et al. Length of hospital stay and postdischarge mortality in patients with pulmonary embolism: a statewide perspective. Arch Intern Med 2008; 168(7): 706–712.CrossRefGoogle ScholarPubMed
Bledsoe, J, Hamilton, D, Bess, E, et al. Treatment of low-risk pulmonary embolism patients in a chest pain unit. Crit Pathw Cardiol 2010; 9(4): 212–215.CrossRefGoogle Scholar
Ceriani, E, Combescure, C, Le Gal, G, et al. Clinical prediction rules for pulmonary embolism: a systematic review and meta-analysis. J Thromb Haemost 2010; 8(5): 957–970.CrossRefGoogle ScholarPubMed
Douma, RA, Mos, IC, Erkens, PM, et al. Performance of 4 clinical decision rules in the diagnostic management of acute pulmonary embolism: a prospective cohort study. Ann Intern Med 2011; 154(11): 709–718.CrossRefGoogle ScholarPubMed
Righini, M, Perrier, A, DeMoerloose, P, et al. D-Dimer for venous thromboembolism diagnosis: 20 years later. J Thromb Haemost 2008; 6(7): 1059–1071.CrossRefGoogle ScholarPubMed
van Belle, A, Buller, HR, Huisman, MV, et al. Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography. JAMA 2006; 295(2): 172–179.Google ScholarPubMed
Qaseem, A, Snow, V, Barry, P, et al. Current diagnosis of venous thromboembolism in primary care: a clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians. Ann Intern Med 2007; 146(6): 454–458.CrossRefGoogle ScholarPubMed
The PIOPED Investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). JAMA 1990; 263(20): 2753–2759.CrossRefGoogle Scholar
Le Gal, G, Righini, M, Boehlen, F, et al. A positive compression ultrasonography of the lower limb veins is highly predictive of pulmonary embolism on computed tomography in suspected patients. Thromb Haemost 2006; 95(6): 963–966.Google ScholarPubMed
Lankeit, M, Konstantinides, S. Mortality risk assessment and the role of thrombolysis in pulmonary embolism. Clin Chest Med 2010; 31(4): 759–769.CrossRefGoogle ScholarPubMed
Becattini, C, Vedovati, MC, Agnelli, G. Prognostic value of troponins in acute pulmonary embolism: a meta-analysis. Circulation 2007; 116(4): 427–433.CrossRefGoogle ScholarPubMed
Wicki, J, Perrier, A, Pemeger, TV, et al. Predicting adverse outcome in patients with acute pulmonary embolism: a risk score. Thromb Haemost 2000; 84(4): 548–552.CrossRefGoogle ScholarPubMed
Uresandi, F, Otero, R, Cayuela, A, et al. A clinical prediction rule for identifying short-term risk of adverse events in patients with pulmonary thromboembolism. Arch Bronconeumol 2007; 43(11): 617–622.CrossRefGoogle ScholarPubMed
Murugappan, M, Johnson, JA, Gage, BF, et al. Home Management Exclusion (HOME) criteria for initial treatment of acute pulmonary embolism. Am J Respir Crit Care Med 2008; 177: A182.Google Scholar
Nendaz, MR, Bandelier, P, Aujesky, D, et al. Validation of a risk score identifying patients with acute pulmonary embolism, who are at low risk of clinical adverse outcome. Thromb Haemost 2004; 91(6): 1232–1236.Google ScholarPubMed
Aujesky, D, LeManach, CD, et al. Validation of a model to predict adverse outcomes in patients with pulmonary embolism. Eur Heart J 2006; 27(4): 476–481.CrossRefGoogle Scholar
Otero, R, Jimenez, D. Pulmonary embolism at home. Eur Respir J 2008; 31(3): 686–687; author reply 687.CrossRefGoogle ScholarPubMed
Aujesky, D, Obrosky, DS, Stone, RA, et al. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med 2005; 172(8): 1041–1046.CrossRefGoogle ScholarPubMed
Venetz, C, Jimenez, D, Mean, M, et al. A comparison of the original and simplified Pulmonary Embolism Severity Index. Thromb Haemost 2011; 106(3): 423–428.CrossRefGoogle ScholarPubMed
Konstantinides, S, Torkicki, A, Agnelli, G, et al. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism. European Heart Journal 2014; 35(43): 3033–3069.Google ScholarPubMed
Kearon, C, Akl, EA, Comerota, AJ, et al. Antithrombotic Therapy for VTE Disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141(2 Suppl): e419S–94S.CrossRefGoogle ScholarPubMed
Kearon, C, Akl, EA, Ornelas, J, et al. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest 2016; 149.CrossRefGoogle Scholar
FDA expands use of Xarelto to treat, reduce recurrence of blood clots. November 8, 2012; Available from: www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm326654.htm. (Accessed March 2016)Google Scholar
Einstein PE Investigators: Buller, HR, Prins, MH, Lensin, AW, et al. Oral rivaroxaban for the treatment of Symptomatic Pulmonary Embolism. N Engl J Med 2012; 366(14): 1287–1297.Google ScholarPubMed
Agnelli, G, Buller, HR, Cohen, A, et al. Oral Apixaban for the treatment of Acute Venous Thromboembolism. NEJM 2013; 369(9): 799–808.CrossRefGoogle ScholarPubMed
Hokusai-VTE Investigators: Buller, HR, Decousus, H, Gross, MA, et al. Edoxaban versus Warfarin for the treatment of Symptomatic Venous Thromboembolism. NEJM 2013; 369: 1406–1415.Google ScholarPubMed
Schulman, S, Kearon, C, Kakkar, AK, et al. Re-Cover Study Group. Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med 2009; 361(24): 2342–2352.CrossRefGoogle Scholar
Kearon, C, Akl, EA, Comerota, AJ, et al. Antithrombotic Therapy for VTE Disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141(2 Suppl): e419S–94S.CrossRefGoogle ScholarPubMed
Van Der Hulle, T, Kooiman, J, den Exter, PL, et al. Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis. Journal of Thrombosis and Haemostasis 2014; 12: 320–328.CrossRefGoogle ScholarPubMed